WHO expects to review Chinese Covid-19 vaccines on April 26: Official

WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility.
Employees pick up vials containing CoronaVac, Sinovac's vaccine against Covid-19, in Sao Paulo, Brazil.(REUTERS / File)
Employees pick up vials containing CoronaVac, Sinovac's vaccine against Covid-19, in Sao Paulo, Brazil.(REUTERS / File)
Updated on Apr 09, 2021 07:48 PM IST
Copy Link
Reuters | , Geneva

China's Covid-19 vaccines, made by Sinopharm and Sinovac, are in final stages of review for emergency use listing by the World Health Organization (WHO) which expects to decide on at least one at an April 26 meeting, its regulation director Rogerio Gaspar said on Friday.

A second meeting was planned for the week of May 3, which would allow for reviewing the second one as needed, he said.

WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility and is also a signal to countries with weaker regulatory agencies about a vaccine's safety and efficacy.

SHARE THIS ARTICLE ON
Close Story
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Saturday, January 22, 2022